Cryo-Cell International, Inc. (CCEL) Reports Q3 EPS of $0.06

Cryo-Cell International, Inc. (NASDAQ: CCEL) reported Q3 EPS of $0.06. Revenue for the quarter came in at $7.7 million, versus $0 reported last year.

For earnings history and earnings-related data on Cryo-Cell International, Inc. (CCEL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c